Latest Quarterly Report
Filed: 2026-05-15
Key Insights
- Balance Labs shows significant related-party transaction activity with Michael Farkas and The Farkas Group Inc, including multiple notes payable and short-term advances, indicating potential cash flow dependency on insider financing rather than operational cash generation.
- The company maintains convertible debt instruments (Chase Mortgage Convertible Notes and CEO convertible notes) with fair value measurements across multiple levels, suggesting potential dilution risk to existing shareholders upon conversion.
- Subsequent events through May 11, 2026 show continued transactions with The Farkas Group Inc, indicating ongoing related-party dealings that may raise corporate governance concerns and require close monitoring of insider influence on company operations.
- The filing structure shows multiple categories of notes payable from various related parties (CEO loans, Foundation, Balance Group LLC, pre-conversion agreements), suggesting a complex capital structure with potential refinancing and repayment obligations that could strain liquidity.